Felisa V. Leguizamon

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study.

Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study.

Journal: Journal of the neurological sciences

Published: August 11, 2025

Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments.

Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments.

Journal: Multiple sclerosis and related disorders

Published: June 10, 2025

Determination of disability progression in moderately and highly disabled ambulatory patients with relapsing-remitting multiple sclerosis using the EDSS-Plus: A prospective study in Argentina.

Determination of disability progression in moderately and highly disabled ambulatory patients with relapsing-remitting multiple sclerosis using the EDSS-Plus: A prospective study in Argentina.

Journal: Multiple sclerosis and related disorders

Published: December 19, 2024

Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.

Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.

Journal: Clinical neuropharmacology

Published: July 15, 2024

Factors influencing recovery in a pediatric sample with disorders of consciousness: insights from an observational study.

Factors influencing recovery in a pediatric sample with disorders of consciousness: insights from an observational study.

Journal: Brain injury

Published: July 05, 2024

Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study.

Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study.

Journal: Frontiers in immunology

Published: May 11, 2024

Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study.

Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study.

Journal: Journal of the neurological sciences

Published: May 04, 2024

Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).

Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).

Journal: Multiple sclerosis and related disorders

Published: February 26, 2024

Clinical effectiveness of dimethyl fumarate in multiple sclerosis patients from Argentina.

Clinical effectiveness of dimethyl fumarate in multiple sclerosis patients from Argentina.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 17, 2024

Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness.

Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 29, 2024

Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients.

Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 22, 2024

Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.

Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.

Journal: Journal of neurology

Published: January 20, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026